Related Experiment Video
Updated: Dec 22, 2025
06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
571
Disparities in Gynecological Malignancies
Sudeshna Chatterjee1, Divya Gupta1, Thomas A Caputo1
1Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Weill Cornell Medical College, New York Presbyterian Hospital , New York, NY , USA.
Frontiers in Oncology
|March 5, 2016
Summary
Black women face significant health disparities in gynecological cancer care, with lower survival rates and less access to evidence-based treatment compared to White women. Addressing these barriers is crucial for equitable outcomes.
Area of Science:
- Gynecologic Oncology
- Health Disparities Research
- Healthcare Access
Background:
- Health disparities and inequalities in U.S. healthcare access persist across socioeconomic, ethnic, and racial groups.
- These disparities are well-documented within the U.S. healthcare system, impacting various patient populations.
Purpose of the Study:
- To review barriers contributing to health disparities in gynecological oncology management.
- To detail site-specific disparities in endometrial, ovarian, and cervical cancer care.
Main Methods:
- A literature review was conducted using PubMed and Google Scholar.
- Peer-reviewed academic and governmental publications on U.S. gynecological care disparities were analyzed.
Main Results:
- Disparities stem from geographic access, hospital variations, research inequities, socioeconomic status, insurance, race, and biological factors.
- Black women exhibit significantly lower 5-year survival rates for all gynecologic cancers compared to White women.
- Black patients with ovarian and endometrial cancers receive less guideline-consistent treatment and have worse outcomes, even when controlling for stage and comorbidities.
Conclusions:
- Gynecologic cancer disparities are complex, involving biological, racial, socioeconomic, and geographic factors influencing treatment and survival.
- Addressing these multifaceted barriers is essential for delivering equitable and optimal care to all women in the U.S.
